<span style="font-size: 16pt; font-family: Calibri,sans-serif; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Acute Kidney Injury
Acute Kidney Injury (AKI), also known as acute renal failure (ARF), is a condition characterized by azotemia that progresses over several hours or days, with or without oliguria. AKI is commonly defined as an abrupt decline in renal function, clinically manifesting as a reversible acute increase in nitrogen waste products measured by blood urea nitrogen (BUN) and serum creatinine levels over the course of hours to weeks. The disease leads to an abrupt loss of kidney function, leading to the retention of waste products, electrolyte disturbances, and volume status changes.
<a style="text-decoration-line: none;" href="https://www.delveinsight.com/report-store/acute-kidney-injury-aki-epidemiology-forecast"><span style="font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; background-color: transparent; font-weight: bold; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; vertical-align: baseline; white-space-collapse: preserve;">Acute Kidney Injury Epidemiology Segmentation in the 7MM</a>
<ul>
<li dir="ltr" style="line-height: 1.38;" role="presentation"><span style="font-size: 11pt; background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; vertical-align: baseline; text-wrap-mode: wrap;">Total Incident Population of AKI in Hospitalized Patients</li>
<li dir="ltr" style="line-height: 1.38;" role="presentation"><span style="font-size: 11pt; background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; vertical-align: baseline; text-wrap-mode: wrap;">Mortality Adjusted Incident Population of AKI in Hospitalized Patients</li>
<li dir="ltr" style="line-height: 1.38;" role="presentation"><span style="font-size: 11pt; background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; vertical-align: baseline; text-wrap-mode: wrap;">Stage-specific Incident Population of AKI</li>
<li dir="ltr" style="line-height: 1.38;" role="presentation"><span style="font-size: 11pt; background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; vertical-align: baseline; text-wrap-mode: wrap;">Age-specific Incident Population of AKI</li>
</ul>
<a style="text-decoration-line: none;" href="https://www.delveinsight.com/report-store/acute-kidney-injury-aki-epidemiology-forecast"><span style="font-size: 11pt; font-family: Calibri, sans-serif; color: #1155cc; background-color: transparent; font-weight: bold; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; text-decoration-line: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space-collapse: preserve;">Acute Kidney Injury Epidemiological Insights</a><span style="font-size: 11pt; font-family: Calibri, sans-serif; background-color: transparent; font-weight: bold; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; vertical-align: baseline; white-space-collapse: preserve;"> Observed in the 7MM
<span style="font-size: 11pt; font-family: Calibri, sans-serif; background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; vertical-align: baseline; white-space-collapse: preserve;">The total Mortality-adjusted Incident Cases of Acute Kidney Injury in the 7MM comprised 14.6 million cases in 2022.
<a style="text-decoration-line: none;" href="https://www.delveinsight.com/report-store/acute-kidney-injury-aki-market"><span style="font-size: 11pt; font-family: Calibri, sans-serif; color: #1155cc; background-color: transparent; font-weight: bold; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; text-decoration-line: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space-collapse: preserve;">Acute Kidney Injury Market Insight</a>
<span style="font-size: 11pt; font-family: Calibri, sans-serif; background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; vertical-align: baseline; white-space-collapse: preserve;">The total market size of Acute Kidney Injury in the 7MM was ~USD 6.2 billion in 2022 and is projected to grow during the forecast period (2024-2034).
<span style="font-size: 11pt; font-family: Calibri, sans-serif; background-color: transparent; font-weight: bold; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; vertical-align: baseline; white-space-collapse: preserve;">Acute Kidney Injury Market Strengths
<span style="font-size: 11pt; font-family: Calibri, sans-serif; background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; vertical-align: baseline; white-space-collapse: preserve;">The pipeline of AKI is quite robust, with diverse products strengthening the upcoming market.
<span style="font-size: 11pt; font-family: Calibri, sans-serif; background-color: transparent; font-weight: bold; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; vertical-align: baseline; white-space-collapse: preserve;">Acute Kidney Injury Market Opportunities
<span style="font-size: 11pt; font-family: Calibri, sans-serif; background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; vertical-align: baseline; white-space-collapse: preserve;">History and physical exams help identify causes of Acute Kidney Injury, such as nephrotoxic drugs or systemic illnesses. AKI diagnosis relies on serum creatinine increase or reduced urine output, with lab tests like creatinine, urinalysis, and renal biopsy providing further insights.
<a style="text-decoration-line: none;" href="https://www.delveinsight.com/report-store/acute-kidney-injury-aki-pipeline-insight"><span style="font-size: 11pt; font-family: Calibri, sans-serif; color: #1155cc; background-color: transparent; font-weight: bold; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; text-decoration-line: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space-collapse: preserve;">Acute Kidney Injury Emerging Drugs and Key Companies</a>
<ul>
<li dir="ltr" style="line-height: 1.38;" role="presentation"><span style="font-size: 11pt; background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; vertical-align: baseline; text-wrap-mode: wrap;">RBT-1 (Renibus Therapeutics)</li>
<li dir="ltr" style="line-height: 1.38;" role="presentation"><span style="font-size: 11pt; background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; vertical-align: baseline; text-wrap-mode: wrap;">OCE-205 (Ocelot Bio)</li>
<li dir="ltr" style="line-height: 1.38;" role="presentation"><span style="font-size: 11pt; background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; vertical-align: baseline; text-wrap-mode: wrap;">APX-115 (AptaBio Therapeutics)&nbsp;</li>
<li dir="ltr" style="line-height: 1.38;" role="presentation"><span style="font-size: 11pt; background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; vertical-align: baseline; text-wrap-mode: wrap;">Ilofotase alfa (AM-Pharma)</li>
<li dir="ltr" style="line-height: 1.38;" role="presentation"><span style="font-size: 11pt; background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; vertical-align: baseline; text-wrap-mode: wrap;">bRESCAP (Alloksys Life Sciences)</li>
</ul>
<h2 dir="ltr" style="line-height: 1.38; background-color: #ffffff; margin-top: 12pt; margin-bottom: 0pt; padding: 0pt 0pt 12pt 0pt;"></h2>

Acute Kidney Injury  Market

Acute Kidney Injury Market Infographic

Acute Kidney Injury Symptoms, Treatment, epidemiology, companies, drugs infographic is a short guide to understand the problem and market landscape.